-
is on advancing the state-of-the-art in generative modeling and applying these advances toward developing more capable biotechnologies, including design problems that go beyond the molecular scale. We
-
immunotherapeutic approaches for fusion oncogene driven AML towards a career in academics, biotechnology or pharmaceutical industry. The applicant should have a strong background in immunology, cancer biology
-
focus is on advancing the state-of-the-art in generative modeling and applying these advances toward developing more capable biotechnologies, including the design of more evolutionarily resilient
-
immunotherapeutic approaches for fusion oncogene driven AML towards a career in academics, biotechnology or pharmaceutical industry. The applicant should have a strong background in immunology, cancer biology
-
(Nature 2017; Nature Biotechnology 2020; Cell 2020), which we applied to gain mechanistic insights into disease (Nature Medicine 2018; Nature Medicine 2020). Our ultimate goal is to identify novel and